Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited et al
| Otsuka Pharmaceutical Co., Ltd. |
| Lupin Pharmaceuticals, Inc. and Lupin Limited |
| 1:2021cv00900 |
| June 23, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 26, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 8
WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For Lupin Limited waiver sent on 7/7/2021, answer due 9/7/2021. (Blumenfeld, Jack)
|
|
Filing 7
WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For Lupin Pharmaceuticals, Inc. waiver sent on 7/7/2021, answer due 9/7/2021. (Blumenfeld, Jack)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 6
Summonses Issued (please complete the top portion of the form and print out for use/service). (Attachments: #1 Summons- Lupin Pharma)(smg)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (smg)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 ; 10,905,694. (smg)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 11, 2021. Date of Expiration of the '730 Patent: September 1, 2026 Date of Expiration of the '694 Patent: April 7, 2030.Thirty Month Stay Deadline: 11/11/2023. (smg) Modified on 6/24/2021 (smg).
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg)
|
|
Filing 1
COMPLAINT for PATENT INFRINGEMENT- filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3642051.) - filed by Otsuka Pharmaceutical Co., Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(smg) Modified on 6/24/2021 (smg).
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
